share_log

カイオム・バイオサイエンス:当社の抗CX3CR1抗体に関する独占的ライセンス契約締結のお知らせ

Chiome Bioscience: Announcement of the conclusion of an exclusive license agreement for our anti-CX3CR1 antibody

JPX ·  Nov 20 01:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more